title: Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity.
abstract: We report that in Jurkat T cells or freshly isolated T lymphocytes, physiological concentrations of high-molecular weight sulfated polysaccharides such as heparin, heparan sulfate, and dextran sulfate significantly increased the percentage of cell death induced by Fas IgM agonistic antibody. The phenomenon was caspase dependent and P53 independent and correlated with an increased accessibility of cell surface Fas receptors. We also observed that the Fas IgM agonistic antibody-dependent formation of sodium dodecyl sulfate (SDS)-resistant large structures containing Fas receptor was decreased in the presence of heparin-like agents. In contrast, the different agents had no effect when cell death was triggered by FasL, the natural ligand of Fas that does not generate SDS-resistant forms of Fas. Interestingly, the synergistic effect of heparin-like agents toward Fas IgM agonistic antibody-mediated cell death abolished Hsp27 antiapoptotic activity but did not alter much the protection generated by Bcl-2 expression.
authors.affiliation: Laboratoire Stress Oxydant, Chaperons et Apoptose, Centre de Génétique Moléculaire et Cellulaire, CNRS UMR 5534, Université Claude Bernard Lyon-l, Villeurbanne, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Manero
authors.forename: Vesna
authors.initials: V
authors.lastname: Ljubic-Thibal
authors.forename: Maryline
authors.initials: M
authors.lastname: Moulin
authors.forename: Nadège
authors.initials: N
authors.lastname: Goutagny
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Yvin
authors.forename: André-Patrick
authors.initials: AP
authors.lastname: Arrigo
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects* / Q000276:immunology; D020169:Caspases / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D002470:Cell Survival; D016264:Dextran Sulfate / Q000494:pharmacology; D004587:Electrophoresis, Agar Gel; D005434:Flow Cytometry; D050886:HSP20 Heat-Shock Proteins; D006367:HeLa Cells; D006360:Heat-Shock Proteins / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000494:pharmacology; D006801:Humans; D015151:Immunoblotting; D019169:Jurkat Cells; D007739:L Cells; D008213:Lymphocyte Activation; D051379:Mice; D010750:Phosphoproteins / Q000187:drug effects*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000502:physiology*; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects; D019014:fas Receptor / Q000276:immunology* / Q000502:physiology
chemical_list: D000911:Antibodies, Monoclonal; D020169:Caspases; D016264:Dextran Sulfate; D050886:HSP20 Heat-Shock Proteins; D006360:Heat-Shock Proteins; D006493:Heparin; D006497:Heparan Sulfate; D010750:Phosphoproteins; D019253:Proto-Oncogene Proteins c-bcl-2; D019014:fas Receptor; C494382:HSPB6 protein, human